1-10 of 10
Laura Rosiñol, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Value of Antigen Expression in Multiple Myeloma (MM): A Large GEM/Pethema Study Based in Four Consecutive Clinical Trials

Bruno Paiva, PhD, Noemi Puig, MD PhD, Paula Arana, Teresa Cedena, Lourdes Cordon, Maria Belen Vidriales, MD PhD, Norma C Gutierrez, Joaquin Martinez-López, MDPhD, Miguel T Hernandez, Ana Isabel Teruel, MD, Mercedes Gironella, M Asuncion Echeveste, Laura Rosiñol, MDPhD, Rafael Martinez, MD, Albert Oriol, MDPhD, Javier De La Rubia, Joan Blade, MDPhD, Juan Jose Lahuerta, Maria-Victoria Mateos, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 19.
https://doi.org/10.1182/blood.V126.23.19.19
Published: 2015
Journal Articles

Usefulness of Serum-Free-Light-Chains-Ratio (SFLCR) and Serum Heavy-Light-Chains-Ratio (SHLCR) in Multiple Myeloma in the Context of Three GEM/Pethema Clinical Trials

Lucia Lopez-Anglada, MDPhD, Cecilia Cueto-Felgueroso, Maria-Victoria Mateos, Laura Rosiñol, MDPhD, Albert Oriol, MDPhD, Ana Isabel Teruel, MD, Ana Lopez de la Guia, MD, Luis Palomera, MDPhD, Felipe de Arriba, MDPhD, Jose Mariano Hernandez, MD, Miquel Granell, MD, Francisco Javier Peñalver, MD, Ramon Garcia-Sanz, MDPhD, Juan Besalduch, MDPhD, Yolanda Gonzalez, MD, Rafael Martinez, MDPhD, Miguel Teodoro Hernandez, MDPhD, Norma C Gutierrez, Paloma Puerta, MD, Joan Blade, MDPhD, Jesús San Miguel, MDPhD, Juan José Lahuerta, MDPhD, Joaquin Martinez Lopez, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2962.
https://doi.org/10.1182/blood.V126.23.2962.2962
Published: 2015
Journal Articles

Comparison Between First-Generation 4-Color Vs. Second-Generation 8-Color Multiparameter Flow Cytometry (MFC) to Monitor Minimal Residual Disease (MRD) in Multiple Myeloma (MM)

Paula Arana, Bruno Paiva, PhD, Maria Belen Vidriales, MD PhD, Juan A Flores-Montero, MD, Noemi Puig, MD PhD, Teresa Cedena, Lourdes Cordon, Joaquin Martinez-López, MDPhD, Enrique M. Ocio, MD PhD, Miguel T Hernandez, Ana Isabel Teruel, MD, Mercedes Gironella, M Asuncion Echeveste, Laura Rosiñol, MDPhD, Joan Blade, MDPhD, Juan Jose Lahuerta, Jacques J.M. van Dongen, Alberto Orfao, MD PhD, Maria-Victoria Mateos, Jesus San Miguel, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2963.
https://doi.org/10.1182/blood.V126.23.2963.2963
Published: 2015
Journal Articles

The Relevance of Minimal Residual Disease (MRD) Monitoring in Elderly Multiple Myeloma (MM) Patients

Bruno Paiva, PhD, Teresa Cedena, Noemi Puig, MD PhD, Lourdes Cordon, Joaquin Martinez-López, MDPhD, Enrique M. Ocio, MD PhD, Miguel T Hernandez, Ana Isabel Teruel, MD, Mercedes Gironella, M Asuncion Echeveste, Laura Rosiñol, MDPhD, Rafael Martinez, MD, Albert Oriol, MDPhD, Jesus Martin, Norma C Gutiérrez, Maria Belen Vidriales, MD PhD, Joan Blade, MDPhD, Juan Jose Lahuerta, Maria-Victoria Mateos, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4181.
https://doi.org/10.1182/blood.V126.23.4181.4181
Published: 2015
Journal Articles

Prognostic Value of Immune Profiling Multiple Myeloma Patients during Minimal Residual Disease Monitoring in the Pethema/GEM2010MAS65 Study

Paula Arana, Bruno Paiva, PhD, Noemi Puig, MD PhD, Teresa Cedena, Lourdes Cordon, Maria Belen Vidriales, MD PhD, Joaquin Martinez-López, MDPhD, Enrique M. Ocio, MD PhD, Miguel T Hernandez, Ana Isabel Teruel, MD, Mercedes Gironella, M Asuncion Echeveste, Laura Rosiñol, MDPhD, Rafael Martinez, MDPhD, Albert Oriol, MDPhD, Joan Blade, MDPhD, Juan Jose Lahuerta, Maria-Victoria Mateos, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 721.
https://doi.org/10.1182/blood.V126.23.721.721
Published: 2015
Journal Articles

What Is the Frequency of Transplant-Eligible Multiple Myeloma Patients Being Cured? the Impact of an MGUS-like Signature at Diagnosis and MRD-Negativity

Bruno Paiva, PhD, Maria Belen Vidriales, MD PhD, Noemi Puig, MD PhD, Teresa Cedena, Lourdes Cordon, Maria-Victoria Mateos, Joaquin Martinez-López, MDPhD, Laura Rosiñol, MDPhD, Alfonso Garcia de Coca, MD PhD, Natalia De Las Heras, MD, Josefina Galende, Jose Mariano Hernandez, MD, Luis Palomera, MDPhD, Javier De La Rubia, Joan Blade, MDPhD, Jesus San Miguel, MDPhD, Juan Jose Lahuerta
Journal: Blood
Blood (2015) 126 (23): 725.
https://doi.org/10.1182/blood.V126.23.725.725
Published: 2015
Journal Articles

Bortezomib Plus Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) in Newly Diagnosed Elderly Myeloma Patients Overcome the Poor Prognosis of High-Risk Cytogenetic Abnormalities (CA) Detected By Fluorescence in Situ Hibridization (FISH)

Maria-Victoria Mateos, Norma C Gutierrez, María-Luisa Martín, Joaquín Martínez-López, MD PhD, Miguel T Hernandez, Rafael Martinez, MDPhD, Laura Rosiñol, MDPhD, Enrique M. Ocio, MD PhD, Ana Isabel Teruel, MD, Albert Oriol, MDPhD, Juan Jose Bargay, Enrique Bengoechea, Yolanda Gonzalez, MD, Jaime Perez De Oteyza, Mercedes Gironella, Cristina Encinas, Jesus Martin, Carmen Cabrera, Bruno Paiva, PhD, Noemi Puig, MD PhD, Joan Blade, MDPhD, Juan José Lahuerta, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4243.
https://doi.org/10.1182/blood.V126.23.4243.4243
Published: 2015
Journal Articles

Serial Echocardiographic Assessment of Patients (Pts) with Relapsed Multiple Myeloma (RMM) Receiving Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd): A Substudy of the Phase 3 Endeavor Trial (NCT01568866)

Stuart D Russell, Alexander Lyon, Daniel J. Lenihan, MD, Philippe Moreau, Douglas Joshua, Wee-Joo Chng, Antonio Palumbo, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Heinz Ludwig, Ludek Pour, MD, Ruben Niesvizky, Albert Oriol, MDPhD, Laura Rosiñol, MDPhD, Aleksandr Suvorov, Gianluca Gaidano, Vesselina Goranova-Marinova, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Meletios A. Dimopoulos
Journal: Blood
Blood (2015) 126 (23): 4250.
https://doi.org/10.1182/blood.V126.23.4250.4250
Published: 2015
Journal Articles

Bortezomib, Melphalan, Prednisone (VMP) and Lenalidomide Plus Dexamethasone (Rd) Is the Optimal Combination for Patients with Newly Diagnosed Multiple Myeloma (MM) Patients Between 65 and 80 Years

Maria-Victoria Mateos, MD PhD, Joaquín Martínez-López, Miguel T Hernandez, Enrique M Ocio, Laura Rosiñol, MDPhD, Rafael Martinez, MD, Ana Isabel Teruel, MD, Norma C Gutierrez, María-Luisa Martín, Albert Oriol, MD, Joan Bargay, MD, Enrique Bengoechea, Yolanda Gonzalez, MD, Jaime Perez de Oteyza, Mercedes Gironella, Cristina Encinas, Carmen Cabrera, Bruno Paiva, PhD, Maria Teresa Cedena, Noemi Puig, MD PhD, Joan Blade, MDPhD, Juan José Lahuerta, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1848.
https://doi.org/10.1182/blood.V126.23.1848.1848
Published: 2015
Journal Articles

Low-Dose Dexamethasone Does Not Abrogate the Immunomodulatory Effects of Lenalidomide and Both Reactivate the Impaired Immune System of High-Risk Smoldering Multiple Myeloma Patients

Bruno Paiva, PhD, Maria-Victoria Mateos, Luis Ignacio Sánchez-Abarca, Maria Belen Vidriales, MD PhD, Lucia Lopez-Corral, MD, Luis A Corchete, Miguel T Hernandez, Joan Bargay, MD PhD, Felipe De Arriba, Javier De La Rubia, Ana Isabel Teruel, MD, Pilar Giraldo, MD PhD, Laura Rosiñol, MDPhD, Felipe Prosper, MD, Albert Oriol, MDPhD, Jose Mariano Hernandez, MD, Graça Esteves, Fernando Leal da Costa, Juan Jose Lahuerta, Joan Blade, MDPhD, Jose A. Perez-Simon, MD, PhD, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2955.
https://doi.org/10.1182/blood.V126.23.2955.2955
Published: 2015